Synthesis and Biological Evaluation of Analogues of 7-Chloro-4,5-dihydro-4-oxo-8-(1,2,4-triazol-4-yl)-1,2,4-triazolo[1,5-a] quinoxaline-2-carboxylic Acid (TQX-173) as Novel Selective AMPA Receptor Antagonists
ANIMAL TISSUE;
ARTICLE;
BINDING ASSAY;
CONTROLLED STUDY;
DRUG BINDING SITE;
DRUG POTENCY;
DRUG RECEPTOR BINDING;
DRUG SCREENING;
DRUG SELECTIVITY;
DRUG SYNTHESIS;
ELECTRON TRANSPORT;
NONHUMAN;
RAT;
RECEPTOR AFFINITY;
STRUCTURE ACTIVITY RELATION;
Ligands for glutamate receptor: Design and therapeutic prospects
Bräuner-Osborne, H.; Egebjerg, J.; Nielsen, E. Ø.; Madsen, U.; Krogsgaard-Larsen, P. Ligands for glutamate receptor: Design and therapeutic prospects. J. Med. Chem. 2000, 43, 2609-2645.
Pharmacology of AMPA/Kainate receptor ligands and their therapeutic potential in neurological and psychiatric disorders
Lees, G. J. Pharmacology of AMPA/Kainate receptor ligands and their therapeutic potential in neurological and psychiatric disorders. Drugs 2000, 59, 33-78.
AMPA receptor agonists, antagonists and modulators: Their potential for clinical utility
Bigge, C. F.; Nikam, S. S. AMPA receptor agonists, antagonists and modulators: Their potential for clinical utility. Exp. Opin. Ther. Patents 1997, 7, 1099-1114.
The AMPA receptor binding site: Focus on agonists and competitive antagonists
Stensbol, T. B.; Madsen, U.; Krogsgaard-Larsen, P. The AMPA receptor binding site: Focus on agonists and competitive antagonists. Curr. Pharm. Des. 2002, 8, 857-872.
A novel non-NMDA receptor antagonist shows selective displacement of low-affinity [3H]kainate binding
Johansen, T. H.; Drejer, J.; Watjen, F.; Nielsen, E. O. A novel non-NMDA receptor antagonist shows selective displacement of low-affinity [3H]kainate binding. Eur. J. Pharmacol. 1993, 246, 195-204.
A new pyrrolyl-quinoxalinedione series of non-NMDA glutamate receptor antagonists: Pharmacological characterization and comparison with NBQX and valproate in the kindling model of epilepsy
Loscher, W.; Lehmann, H.; Behl, B.; Seemann, D. Teschendorf, H. J. Hofmann, H. P.; Lubisch, W.; Hoger, T.; Lemaire, H. G.; Gross, G. A new pyrrolyl-quinoxalinedione series of non-NMDA glutamate receptor antagonists: Pharmacological characterization and comparison with NBQX and valproate in the kindling model of epilepsy. Eur. J. Neurosci. 1999, 11, 250-262.
Glycine and N-Methyl-D-Aspartate receptors: Physiological significance and possible therapeutic applications
Danysz, W.; Parsons, C. G. Glycine and N-Methyl-D-Aspartate receptors: Physiological significance and possible therapeutic applications. Pharmacol. Rev. 1998, 50, 597-664.
Recent trends in the development of new anti-epileptic drugs
Wolfe, J. F.; Greenwood, T. D.; Mulheron, J. M. Recent trends in the development of new anti-epileptic drugs. Exp. Opin. Ther. Patents 1998, 8, 361-381.
Synthesis and structure-activity relationships of substituted 1,4-dihydroquinoxaline-2,3-diones: Antagonists of N-methyl-D-aspartate(NMDA) receptor glycine sites and non-NMDA glutamate receptors
Keana, J. F. W.; Kher, S. M.; Cai, S. X.; Dinsmore, C. M.; Glenn, A. G.; Guastella, J.; Huang, J. C.; Ilyn, V.; Ilyn, Y.; Mouser, P. L.; Woodward, R. M. ; Weber, E. Synthesis and structure-activity relationships of substituted 1,4-dihydroquinoxaline-2,3-diones: Antagonists of N-methyl-D-aspartate(NMDA) receptor glycine sites and non-NMDA glutamate receptors. J. Med. Chem. 1995, 38, 4367-4379.
Synthesis of 1,4,7,8,9,10-hexahydro-9-methyl-6-nitropyrido[3,4-f]-quinoxaline-2,3-dione and related quinoxalinediones: Characterization of α -amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (and N-methyl-D-aspartate) receptor and anticonvulsant activity
Bigge, C. F.; Malone, T. C.; Boxer, P. A.; Nelson, C. B.; Ortwine, T. F. ; Schelkun, R. M.; Retz, D. M.; Lescosky, L. J.; Borosky, S. A.; Vartanian, M. G.; Schwarz, R. D.; Campbell, G. W.; Robichaud, L. J.; Wätjen, F. Synthesis of 1,4,7,8,9,10-hexahydro-9-methyl-6-nitropyrido[3,4-f]-quinoxaline-2,3-dione and related quinoxalinediones: Characterization of α -amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (and N-methyl-D-aspartate) receptor and anticonvulsant activity. J. Med. Chem. 1995, 38, 3720-3740.
5-(N-oxyaza)-7-substituted-1,4-dihydroquinoxaline-2,3-diones: Novel, systematically active and broad spectrum antagonists for NMDA/ glycine, AMPA, and kainate receptors
Cai, S. X.; Huang, J. C.; Espitia, S. A.; Tran, M.; Ilyn, V. I.; Hawkinson, J. E.; Woodward, R. M.; Weber, E.; Keana, J. F. W. 5-(N-oxyaza)-7-substituted-1,4-dihydroquinoxaline-2,3-diones: Novel, systematically active and broad spectrum antagonists for NMDA/ glycine, AMPA, and kainate receptors. J. Med. Chem. 1997, 40, 3679-3686.
N-Phosphonoalkyl-5-aminomethylquinoxaline-2,3-diones: In vivo active AMPA and NMDA (Glycine) antagonists
Auberson, Y. P.; Acklin, P.; Bishoff, S.; Moretti, R.; Ofner, S. N-Phosphonoalkyl-5-aminomethylquinoxaline-2,3-diones: In vivo active AMPA and NMDA (Glycine) antagonists. Bioorg. Med. Chem. Lett. 1999, 9, 249-254.
The glycine site on the NMDA receptor: Structure-activity relationships and therapeutic potential
Leeson, P. D.; Iversen, L. L. The glycine site on the NMDA receptor: Structure-activity relationships and therapeutic potential. J. Med. Chem. 1994, 37, 4053-4067.
8-(1H-imidazol-1-yl)-7-nitro-4-(5H)-imidazo[1,2-a]quinoxalinone and related compounds: Synthesis and structure activity relationships for the AMPA-type non-NMDA receptor
Homori, J.; Shimizu-Sasamata, M.; Okada, M.; Sakamoto, S. 8-(1H-imidazol-1-yl)-7-nitro-4-(5H)-imidazo[1,2-a]quinoxalinone and related compounds: Synthesis and structure activity relationships for the AMPA-type non-NMDA receptor. J. Med. Chem. 1997, 40, 2053-2063.
Mechanism for activation and antagonism of an AMPA-sensitive glutamate receptor: Crystal strucure of the GluR2 ligand binding core
Armstrong, N.; Gouaux, E. Mechanism for activation and antagonism of an AMPA-sensitive glutamate receptor: Crystal strucure of the GluR2 ligand binding core. Neuron 2000, 28, 165-181.
Competitive antagonism of AMPA receptors by ligands of different classes: Crystal structure of ATPO bound to the GluR2 ligand-binding core, in comparison with DNQX
Hogner, A.; Greenwood, J. R. Liljefors, T.; Lunn, M. L.; Egebjerg, J.; Larsen, I. K.; Gouaux, E.; Kastrup, J. S. Competitive antagonism of AMPA receptors by ligands of different classes: Crystal structure of ATPO bound to the GluR2 ligand-binding core, in comparison with DNQX. J. Med. Chem. 2003, 46, 214-221.
Tricyclic heteroaromatic systems. 3-Substituted 1,2,3,5,6,7-hexahydro-2,5,6-trioxopyrazino[1,2,3-de]-quinoxalines as novel antagonists at the Glycine-NMDA site
Varano, F.; Catarzi, D.; Colotta, V.; Cecchi, L.; Filacchioni G.; Galli, A.; Costagli, C. Tricyclic heteroaromatic systems. 3-substituted 1,2,3,5,6,7-hexahydro-2,5,6-trioxopyrazino[1,2,3-de]-quinoxalines as novel antagonists at the Glycine-NMDA site. Farmaco 1997, 52, 179-182.
Synthesis and biological evaluation of a series of quinazoline-2-carboxylic acids and quinazoline-2,4-diones as glycine-NMDA antagonists: A pharmacophore model based approach
Colotta, V.; Catarzi, D.; Varano, F.; Cecchi, L.; Filacchioni, G.; Galli, A.; Costagli, C. Synthesis and biological evaluation of a series of quinazoline-2-carboxylic acids and quinazoline-2,4-diones as glycine-NMDA antagonists: A pharmacophore model based approach. Arch. Pharm. Pharm. Med. Chem. 1997, 330, 129-134.
Synthesis, Glycine/NMDA and AMPA binding activity of some new 2,5,6-trioxopyrazino[1,2,3-de]quinoxalines and of their restricted analogues 2,5-dioxo- and 4,5-dioxoimidazo[1,5,4-de]quinoxalines
Varano, F.; Catarzi, D.; Colotta, V.; Cecchi, L.; Filacchioni G.; Galli, A.; Costagli, C. Synthesis, Glycine/NMDA and AMPA binding activity of some new 2,5,6-trioxopyrazino[1,2,3-de]quinoxalines and of their restricted analogues 2,5-dioxo- and 4,5-dioxoimidazo[1,5,4-de]quinoxalines. Arch. Pharm. Pharm. Med. Chem. 1999, 332, 201-207.
Synthesis of a set of ethyl 1-carbamoyl-3-oxoquinoxaline-2-carboxylates and of their constrained analogue imidazo[1,5-a]quinoxaline-1,3,4-triones as glycine/NMDA receptor antagonists
Varano, F.; Catarzi, D.; Colotta, V.; Cecchi, L.; Filacchioni G.; Galli, A.; Costagli, C. Synthesis of a set of ethyl 1-carbamoyl-3-oxoquinoxaline-2-carboxylates and of their constrained analogue imidazo[1,5-a]quinoxaline-1,3,4-triones as glycine/NMDA receptor antagonists. Eur. J. Med. Chem. 2001, 36, 203-209.
Synthesis, ionotropic glutamate receptor binding affinity and structure-activity relationships of a new set of 4,5-dihydro-8-heteroaryl-4-oxo-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylates analogues of TQX-173
Catarzi, D.; Colotta; V.; Varano; F.; Filacchioni, G.; Galli, A.; Costagli, C.; Carlà, V. Synthesis, ionotropic glutamate receptor binding affinity and structure-activity relationships of a new set of 4,5-dihydro-8-heteroaryl-4-oxo-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylates analogues of TQX-173. J. Med. Chem. 2001, 44, 3157-3165.
Synthesis and biological evaluation of a new set of pyrazolo[1,5-c]quinazoline-2-carboxylates as novel excitatory amino acid antagonists
Varano, F.; Catarzi, D.; Colotta, V.; Filacchioni, G.; Galli, A.; Costagli, C.; Carlà, V. Synthesis and biological evaluation of a new set of pyrazolo[1,5-c]quinazoline-2-carboxylates as novel excitatory amino acid antagonists. J. Med. Chem. 2002, 45, 1035-1044.
Cardiotonic agents. Synthesis and cardiovascular properties of novel 2-arylbenzimidazole and azabenzimidazole
Güngör, T.; Fouquet, A.; Teulon, J. M.; Provost, D.; Cazes, M. ; Cloarec, A. Cardiotonic agents. Synthesis and cardiovascular properties of novel 2-arylbenzimidazole and azabenzimidazole. J. Med. Chem. 1992, 35, 4455-4463.
Selective block of recombinant GluR6 receptors by NS-102, a novel non-NMDA receptor antagonist
Verdoorn, T. A.; Johansen, T. H.; Drejer, J.; Nielsen, E. O. Selective block of recombinant GluR6 receptors by NS-102, a novel non-NMDA receptor antagonist. Eur. J. Pharmacol. 1994, 269, 43-49.
A quantitative pharmacological analysis of some excitatory amino acid receptors in the mouse neocortex in vitro
Burton, N. R.; Smith, D. A. S.; Stone, T. W. A quantitative pharmacological analysis of some excitatory amino acid receptors in the mouse neocortex in vitro. Br. J. Pharmacol. 1988, 93, 693-701.
N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. I. Location on axon terminals and pharmacological characterization
Pittaluga, A.; Raiteri, M. N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. I. Location on axon terminals and pharmacological characterization. J. Pharmacol. Exp. Ther. 1992, 260, 232-237.
The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist
Wong, E. H. F.; Kemp, J. A.; Priestley, T.; Knight, A. R.; Woodruff, G. N.; Iverson, L. L. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc. Natl. Acad. Sci. U.S.A. 1986, 83, 7104-7108.
Studies on receptor-active conformations of excitatory amino acid agonists and antagonists
Nielsen, E. O.; Madsen, U.; Schaumburg, K.; Brehm, L.; Krogsgaard-Larsen, P. Studies on receptor-active conformations of excitatory amino acid agonists and antagonists. Eur. J. Chem.-Chim. Ther. 1986, 21, 433-437.
Characterization of two central AMPA-preferring receptors having distinct location, function and pharmacology
Pittaluga, A.; Thellung, S.; Maura, G.; Raiteri, M. Characterization of two central AMPA-preferring receptors having distinct location, function and pharmacology. Naunyn-Schmiedeberg's Arch. Pharmacol. 1994, 349, 555-558.
Simultaneous analysis of families of sigmoidal curves: Application to bioassay, radio-ligand assay and physiological dose-response curves
De Lean, A.; Munson, P. J.; Rodbard, D. Simultaneous analysis of families of sigmoidal curves: Application to bioassay, radio-ligand assay and physiological dose-response curves. Am. J. Physiol. 1978, 235, E97-102.
